
The Foundation, through Bio-Manguinhos Institute, signed a Term of Commitment with the National Administration of Laboratories and Institutes of Health Dr. Carlos Malbrán (Anlis), to enable the Argentine institution to produce and supply the yellow fever vaccine in the country